Sandoz Inc. Appeals to Third Circuit in Pursuit of Additional Damages Against United Therapeutics Corp.

Sandoz Inc. is escalating its legal battle by appealing its breach of contract case against United Therapeutics Corp. to the Third Circuit. Despite securing more than $70 million in damages, Sandoz is seeking additional compensation and aims to revive antitrust claims that were previously dismissed by a New Jersey federal court. This legal maneuver outlines Sandoz’s intention to pursue further redress and challenge the earlier court’s ruling. For more on this case, visit Law360.